Tuesday, April 06, 2010 10:24:23 AM
I can't believe the heartless shitty reply I got from the Company in response to my enquiry:-
Mr. Rogers,
Thank you for your interest in Arrowhead Research Corporation. Sorry for the delay in answering your inquiry. We don’t have any information that we can share about Ray Natha. All of the clinical trial information is confidential to the patients and their doctors. Mr. Natha voluntarily shared his story for the documentary in 2007. I did a quick internet search to see if I could find a publicly available update, but I didn’t find anything.
Best regards,
Jane Davidson
what as if they don't know what happened to him? or even care!
Mr. Rogers,
Thank you for your interest in Arrowhead Research Corporation. Sorry for the delay in answering your inquiry. We don’t have any information that we can share about Ray Natha. All of the clinical trial information is confidential to the patients and their doctors. Mr. Natha voluntarily shared his story for the documentary in 2007. I did a quick internet search to see if I could find a publicly available update, but I didn’t find anything.
Best regards,
Jane Davidson
what as if they don't know what happened to him? or even care!
Recent ARWR News
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/12/2026 08:35:16 PM
- Wall Street's Cardiac Bet: Where Diagnostics Meet the Money • PR Newswire (US) • 05/12/2026 12:30:00 PM
- Wall Street's Cardiac Bet: Where Diagnostics Meet the Money • PR Newswire (Canada) • 05/12/2026 12:30:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 05/07/2026 09:27:41 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2026 08:05:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2026 08:02:28 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 04/29/2026 08:44:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/24/2026 10:44:42 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/23/2026 08:44:48 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/22/2026 09:16:20 PM
- Anti-Aging Protein Research Takes a Step Forward with Cell Cloning • PR Newswire (Canada) • 03/24/2026 03:05:00 PM
- Anti-Aging Protein Research Takes a Step Forward with Cell Cloning • PR Newswire (US) • 03/24/2026 03:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/20/2026 08:05:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2026 11:00:06 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2026 09:49:43 PM
- Why Late-Stage CNS, Oncology Assets Are Becoming the Hottest Targets in Biotech M&A • InvestorsHub NewsWire • 02/17/2026 02:00:00 PM
- Why Late-Stage CNS, Oncology Assets Are Becoming the Hottest Targets in Biotech M&A • GlobeNewswire Inc. • 02/17/2026 01:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/05/2026 09:06:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2026 09:05:15 PM
- Ciena Set to Join S&P 500; Arrowhead Pharmaceuticals to Join S&P MidCap 400; ADT and OneSpaWorld Holdings to Join S&P SmallCap 600 • PR Newswire (US) • 02/04/2026 11:15:00 PM
- Longevity Biotech Stocks Surge as $27 Trillion Healthcare Shift Favors Cell Restoration • PR Newswire (Canada) • 01/29/2026 06:31:00 PM
- Longevity Biotech Stocks Surge as $27 Trillion Healthcare Shift Favors Cell Restoration • PR Newswire (US) • 01/29/2026 06:31:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/12/2026 10:00:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/08/2026 11:45:49 PM
